bpc-157 fda warning letter compounding advisory committee votes to add popular peptide to drug list FDA issued 25 warning letters

FDA issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP 1 products. Unlike FDA approved drugs, these products have not been proven to be safe, effective, or of BPC 157 Legal Status: FDA Regulations and Compounding An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with Most FDA advisers say peptides like BPC 157 and TB 500 should be made available in the U.S. Here's what happens next. MarketWatch

SKU: 14322983824 · From iglepidom.org